Retinal microvascular changes detected by OCT-A may provide details for earlier diagnosis of coronary artery stenosis.

Brolucizumab, aflibercept, and faricimab show notable differences in their associations with adverse ocular event.

For the first time since the pandemic began, COVID-19 dropped out of the nation’s top 10 causes of death in 2024, new US ...

High-dose aflibercept in extended treatment intervals can maintain improvements for 96 weeks and stretch dosing visits up to 20 weeks apart.

Federal health officials are reviewing safety data on COVID vaccines in pregnant women and children, and may also reconsider ...

Cessation of Ryan White services, which provide care for more than half of people with HIV in the United States, could yield ...

Nearly 90% of glaucoma surgeries in the US are performed in urban areas, with close to all glaucoma specialists operating there exclusively.

Exposure to inhalable microplastics (1 to 10 µm) that are suspended in indoor air is greater than previously estimated.

In 2023, 55.8% of those with diabetes were diagnosed, and 41.6% had optimal glycemic concentrations on treatment.

More women and those with fellowship training, PhDs, and subspecialty expertise are stepping into ophthalmology department chair roles.

A phase III trial shows that a biosimilar to aflibercept matches the reference drug’s efficacy, safety, and immunogenicity in ...

Certain optical coherence tomography biomarkers may predict visual outcomes in patients with center-involving diabetic macular edema.